ALNY vs MOH · P/E 76, rev $1.29B vs P/E 52, rev $21.67B
Alnylam Pharmaceuticals Inc (ALNY) versus Molina Healthcare Inc (MOH) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Molina Healthcare Inc (MOH) is a healthcare plans company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported MOH revenue for 2026-06-30 was $21.67B. Net income was $74.0M. MOH currently screens at market cap $10.19B and trailing P/E 52.4.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. MOH currently screens at market cap $10.19B and trailing P/E 52.4.
Not investment advice. Open the ALNY and MOH stock pages for the full models.
Not investment advice.